Jingying Qiu

Jiangsu Key Laboratory Of New Drug Research And Clinical Pharmacy
Xuzhou, 221004, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Exploration and optimization of indole derivatives as novel anti-HBV agent with potential TLR7-agonistic effect.

Exploration and optimization of indole derivatives as novel anti-HBV agent with potential TLR7-agonistic effect.

Journal: Bioorganic & medicinal chemistry

Published: December 16, 2025

Discovery of novel third generation P-glycoprotein inhibitors bearing an azo moiety with MDR-reversing effect.

Discovery of novel third generation P-glycoprotein inhibitors bearing an azo moiety with MDR-reversing effect.

Journal: European journal of medicinal chemistry

Published: July 09, 2024

Exploration of 1-(indolin-1-yl)-2-(thiazol-2-yl)ethan-1-one derivatives as novel anti-HBV agent with potential TLR7-agonistic effect.

Exploration of 1-(indolin-1-yl)-2-(thiazol-2-yl)ethan-1-one derivatives as novel anti-HBV agent with potential TLR7-agonistic effect.

Journal: European journal of medicinal chemistry

Published: January 22, 2024

Design and evaluation of dibenzoazepine-tetrahydroisoquinoline hybrids as potential P-glycoprotein inhibitors against multidrug resistant K562/A02 cells.

Design and evaluation of dibenzoazepine-tetrahydroisoquinoline hybrids as potential P-glycoprotein inhibitors against multidrug resistant K562/A02 cells.

Journal: European journal of medicinal chemistry

Published: October 06, 2022

Discovery of benzimidazole substituted 1, 2, 4-oxadiazole compounds as novel anti-HBV agents with TLR8-agonistic activities.

Discovery of benzimidazole substituted 1, 2, 4-oxadiazole compounds as novel anti-HBV agents with TLR8-agonistic activities.

Journal: European journal of medicinal chemistry

Published: August 08, 2022

Design and synthesis of novel quinazolinone derivatives as anti-HBV agents with TLR8 agonist effect.

Design and synthesis of novel quinazolinone derivatives as anti-HBV agents with TLR8 agonist effect.

Journal: European journal of medicinal chemistry

Published: November 12, 2021

Synthesis and Evaluation of Novel Quinazolinone Derivatives as Potential Anti-HCC Agents.

Synthesis and Evaluation of Novel Quinazolinone Derivatives as Potential Anti-HCC Agents.

Journal: Chemistry & biodiversity

Published: September 22, 2021

Assessment of Thiosemicarbazone-Containing Compounds as Potential Antileukemia Agents against P-gp Overexpressing Drug Resistant K562/A02 Cells.

Assessment of Thiosemicarbazone-Containing Compounds as Potential Antileukemia Agents against P-gp Overexpressing Drug Resistant K562/A02 Cells.

Journal: Chemistry & biodiversity

Published: September 17, 2020

Synthesis and evaluation of new phenyl acrylamide derivatives as potent non-nucleoside anti-HBV agents.

Synthesis and evaluation of new phenyl acrylamide derivatives as potent non-nucleoside anti-HBV agents.

Journal: Bioorganic & medicinal chemistry

Published: September 14, 2020

Discovery of thiosemicarbazone-containing compounds with potent anti-proliferation activity against drug-resistant K562/A02 cells.

Discovery of thiosemicarbazone-containing compounds with potent anti-proliferation activity against drug-resistant K562/A02 cells.

Journal: Bioorganic & medicinal chemistry letters

Published: August 18, 2020

Discovery of novel quinazolinone derivatives as potential anti-HBV and anti-HCC agents.

Discovery of novel quinazolinone derivatives as potential anti-HBV and anti-HCC agents.

Journal: European journal of medicinal chemistry

Published: September 14, 2019

Synthesis and assessment of phenylacrylamide derivatives as potential anti-oxidant and anti-inflammatory agents.

Synthesis and assessment of phenylacrylamide derivatives as potential anti-oxidant and anti-inflammatory agents.

Journal: European journal of medicinal chemistry

Published: April 07, 2019

Showing 1-12 of 19

Last Updated: 09/26/2026